Histoplasmosis is a systemic mycosis caused by the thermally dimorphic fungus
Histoplasma capsulatum. Although healthy individuals can develop histoplasmosis, the …

In the current pandemic, COVID-19 patients with predisposing factors are at an increased
risk of mucormycosis, an uncommon angioinvasive infection that is caused by fungi with …

Antifungal medications are vital in combatting fungal diseases that affect over a billion
people annually. Antifungal medications for people and equids are scarce in Ethiopia …

Background Cryptococcal meningitis (CM) and disseminated histoplasmosis (DH) are
common in people with human immunodeficiency virus (PWH) and diagnosed by detecting …

Introduction The management of invasive fungal infections (IFIs) in low-and middle-income
countries (LMIC) is a serious challenge due to limited epidemiology studies, sub-optimal …

Background Fungal infections are common in HIV-infected individuals and significantly
contribute to mortality. However, a substantial number of cases are undiagnosed before …

In sub-Saharan Africa, an estimated 25% of people with HIV present with advanced HIV and
are at high risk of opportunistic infections. Whereas histoplasmosis has occasionally been …

Fungal diseases are associated with high morbidity and mortality, yet their epidemiology
and burden are not well addressed. While deaths probably exceed 1.5 million per year …

Histoplasmosis is an AIDS-defining opportunistic infection. Disseminated histoplasmosis
(DH) can be fatal without early diagnosis and treatment initiation. We present one confirmed …

Objectives: Histoplasmosis is a systemic mycosis, present globally. We aimed to describe
cases of histoplasmosis (Hc) and to establish a risk profile associated with Hc in HIV …